enVVeno Medical Corporation
NVNO | NASDAQ
$9.05
+$0.08 (+0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$9.05
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 528K | 546K | 525K | 452.91K | 383.97K |
Gross Profit | n/a | -528K | -546K | -525K | -452.91K | -383.97K |
Operating Income | -20.9M | -23.83M | -25.24M | -24.93M | -16.89M | -9.14M |
Interest Income | 692K | 389K | 180K | 161K | 18.71K | n/a |
Pretax Income | -19.47M | -21.82M | -23.52M | -24.67M | -16.53M | -9.14M |
Net Income | -19.47M | -21.82M | -23.52M | -24.67M | -16.53M | -9.14M |
Selling & General & Admin | 10.92M | 11.05M | 11.11M | 14.49M | 10.71M | 4.5M |
Research & Development | 9.98M | 12.25M | 13.58M | 9.91M | 5.73M | 4.25M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 20.9M | 23.3M | 24.69M | 24.41M | 16.44M | 8.75M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | -3.74K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.9M | 23.83M | 25.24M | 24.93M | 16.89M | 9.14M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 589.01K | 489.77K | 351.46K | 320.86K | 247.99K | 36.9K |
Shares Outstanding (Diluted) | 589K | 13.99K | 10.04K | 9.17K | 7.09K | 1.05K |
EPS (Basic) | -33.06 | -1.56K | -2.34K | -2.7K | -2.33K | -9.24K |
EPS (Diluted) | -33.06 | -1.56K | -2.34K | -2.7K | -2.33K | -9.24K |
EBITDA | -18.98M | -21.29M | -22.97M | -24.14M | -16.07M | -8.75M |
EBIT | -19.47M | -21.82M | -23.52M | -24.67M | -16.53M | -9.14M |
Depreciation & Amortization | 489K | 528K | 546K | 525K | 452.91K | 383.97K |
Add to Watchlist
Select watchlists to add or remove NVNO